FDA Drug Recalls

Recalls / Class II

Class IID-752-2014

Product

Theraflu Multi-Symptom Severe Cold (acetaminophen 500 mg, dextromethorphan hydrobromide 20 mg, phenylephrine hydrochloride 10 mg) powder packets, Green Tea & Honey Lemon flavors, packaged in a) 6-count packets per carton (NDC 0067-6426-06, UPC 3 0067-6426-06 8) and b) 1-count packet per card (NDC 0067-6426-01, UPC 3 0067-6426-01 3), Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 07054-0622.

Brand name
Theraflu
Generic name
Acetaminophen, Dextromethorphan Hbr, Phenylephrine Hcl
Active ingredients
Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride
Route
Oral
NDC
0067-6426
FDA application
M012
Affected lot / code info
Lot #: a) 10116016, Exp 6/30/2013; 10118931, Exp 7/31/2013; 10121950, Exp 8/31/2013; 10122314, 10122316, 10124226, Exp 9/30/2013; 10124377, 10124379, 10125916, 10128112, 10128114, Exp 10/31/2013; b) 25872801, Exp 7/31/2013

Why it was recalled

Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.

Recalling firm

Firm
Novartis Consumer Health
Manufacturer
Haleon US Holdings LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
10401 Hwy 6, Lincoln, Nebraska 68517-9626

Distribution

Quantity
1,202,960 cartons and cards
Distribution pattern
Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.

Timeline

Recall initiated
2013-06-18
FDA classified
2014-01-17
Posted by FDA
2014-01-29
Terminated
2014-11-04
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-752-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.